Table 1

General characteristics of the study population (N = 5128), their bivariate association with HIV-1 antibody status, and results from random effects multiple regression model.

Variables

Number
%
HIV+
p*
OR (95% CI)
p

Sample source
Detoxification center
2871
56.0
5.8
0.002
1


Community
1621
31.6
4.0

0.77 (0.55–1.09)
0.143

Others1
636
12.4
7.6

0.66 (0.46–0.93)
0.019
Gender
Male
4348
84.8
5.5
0.940
1


Female
780
15.2
5.4

0.73 (0.50–1.07)
0.111
Age
<= 30
2676
52.2
6.2
0.012
1.04 (0.80–1.36)
0.750

> 30
2452
47.8
4.6

1

Marital status
live without partner
2821
55.0
5.1
0.195
1


live with partner
2307
45.0
5.9

1.00 (0.79–1.27)
0.991
Place of residence
Local
4393
85.7
5.9
< 0.001
1


Transient
735
14.3
2.5

1.27 (0.64–2.51)
0.490
Nation
Han
3794
74.0
2.9
< 0.001
1


Minority
1334
26.0
12.7

1.38 (0.93–2.04)
0.107
Education
<= 9 years
1710
33.4
9.0
< 0.001
1


> 9 years
3418
66.6
3.7

1.17 (0.89–1.53)
0.250
Profession
white collar
1744
34.0
8.6
< 0.001
1.18 (0.85–1.64)
0.313

blue collar
3384
66.0
3.8

1

Monthly income
<= 600
2147
41.9
6.9
< 0.001
1


601–2000
1127
22.0
4.5

1.56 (1.13–2.15)
0.007

> 2000
313
6.1
1.9

0.51 (0.24–1.08)
0.080

Missing
1541
30.1
4.7

1.05 (0.79–1.39)
0.751
Age at first drug use
<= 30
4189
81.7
5.5
0.05
1


> 30
707
13.8
4.1

0.71 (0.48–1.05)
0.088

Missing
232
4.5
1.6

0.79 (0.38–1.65)
0.532
IDU and sharing needles (ever)
no IDU
2411
47.0
3.7
< 0.001
1


IDU, no sharing of needles
1506
29.4
4.9

1.89 (1.37–2.61)
< 0.001

IDU, sharing needles
1211
23.6
9.5

3.15 (2.29–4.33)
< 0.001
Having commercial sex in last 12 months
No
4455
86.9
5.5
0.148
1


Yes
85
1.7
9.4

1.33 (0.66–2.70)
0.4265

Missing information
588
11.5
4.4

0.73 (0.50–1.06)
0.102
STD symptoms in last 12 months
No
4418
86.2
5.3
0.338
1


Yes
710
13.9
6.2

0.76 (0.55–1.05)
0.100

1Outreach programs, contacts of known IDU, unknown.

p* Chi-Square

Kretzschmar et al. BMC Infectious Diseases 2008 8:108   doi:10.1186/1471-2334-8-108